Harpoon Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Harpoon Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2022.
  • Harpoon Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $1.07M, a 57.5% decline year-over-year.
  • Harpoon Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2023 was $5.49M, a 46.9% decline year-over-year.
  • Harpoon Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.64M, a 8.73% decline from 2021.
  • Harpoon Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $9.46M, a 94.7% increase from 2020.
  • Harpoon Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $4.86M, a 135% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $8.64M -$826K -8.73% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-27
2021 $9.46M +$4.6M +94.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $4.86M +$2.79M +135% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-27
2019 $2.07M +$1.4M +208% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 $672K +$305K +83.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 $367K +$268K +271% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $99K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.